Expression of AhR-regulated miRNAs in non-small cell lung cancer in smokers and never smokers
Authors:
- 1 February 2024
- journal article
- research article
- Published by Institute of Biochemistry in Biomeditsinskaya Khimiya
- Vol. 70 (1) , 52-60
Abstract
Smoking is a risk factor for non-small cell lung cancer (NSCLC). The most common subtypes of NSCLC are lung adenocarcinoma (LAC) and squamous cell carcinoma (SCC). The cigarette smoke contains aryl hydrocarbon receptor (AhR) ligands, such as benzo(a)pyrene (BaP). By activating the AhR, BaP can change the expression of many genes, including miRNA-encoding genes. In this study, we have evaluated the expression of few miRNAs potentially regulated by AhR (miR-21, -342, -93, -181a, -146a), as well as CYP1A1, a known AhR target gene, in lung tumor samples from smoking (n=40) and non-smoking (n=30) patients with LAC and from smoking patients with SCC (n=40). We have also collected macroscopically normal lung tissue >5 cm from the tumor margin. We compared the obtained data on the miRNA expression in tumors with data from The Cancer Genome Atlas (TCGA). We found that in 76.7% of non-smoking LAC patients, CYP1A1 mRNA was not detected in tumor and normal lung tissues, while in smoking patients, CYP1A1 expression was detected in tumors in almost half of the cases (47.5% for SCC and 42.5% for LAC). The expression profile of AhR-regulated miRNAs differed between LAC and SCC and depended on the smoking status. In LAC patients, the expression of oncogenic miRNA-21 and miRNA-93 in tumors was higher than in normal lung tissue from the same patients. However, in SCC patients from our sample, the levels of these miRNAs in tumor and non-transformed lung tissue did not differ significantly. The results of our studies and TCGA data indicate that the expression levels of miRNA-181a and miRNA-146a in LAC are associated with smoking: expression of these miRNAs was significantly lower in tumors of smokers. It is possible that their expression is regulated by AhR and AhRR (AhR repressor), and inhibition of AhR by AhRR leads to a decrease in miRNA expression in tumors of smoking patients. Overall, these results confirm that smoking has an effect on the miRNA expression profile. This should be taken into account when searching for new diagnostic and therapeutic targets for NSCLC.Keywords
This publication has 26 references indexed in Scilit:
- Influences of polycyclic aromatic hydrocarbon on the epigenome toxicity and its applicability in human health risk assessmentEnvironmental Research, 2022
- Carcinogenic components of tobacco and tobacco smoke: A 2022 updateFood and Chemical Toxicology, 2022
- UALCAN: An update to the integrated cancer data analysis platformNeoplasia, 2022
- Aryl hydrocarbon receptor (AhR) ligands as selective AhR modulators: Genomic studiesCurrent Opinion in Toxicology, 2018
- Overview upon miR-21 in lung cancer: focus on NSCLCCellular and Molecular Life Sciences, 2018
- MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosisGene, 2018
- Genome-wide mapping and analysis of aryl hydrocarbon receptor (AHR)- and aryl hydrocarbon receptor repressor (AHRR)-binding sites in human breast cancer cellsArchives of Toxicology, 2017
- Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug targetArchives of Toxicology, 2017
- The AH Receptor in Biology and Toxicology2011
- Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources of interindividual variability in the baseline excretion of 1-hydroxypyrene in urineInternational Archives of Occupational and Environmental Health, 1994